Friedreich’s ataxia
Clinical research activity is centered on Friedreich’s ataxia, with attention to neurological impairment, progressive motor dysfunction, and measures of functional capacity relevant to daily activity and disease burden.
- Neuromuscular disease
- Movement disorder
- Functional disability
The sponsor’s research interest in this area includes outcomes tied to exercise performance and established clinical rating scales used to track changes in ataxia severity.
Neurological function and disease progression
The clinical focus extends to the preservation and measurement of neurological function in a rare inherited disorder, with emphasis on progression-related symptoms that affect coordination, mobility, and overall physical performance.
- Coordination impairment
- Motor performance
- Disease severity assessment
Research activity in this domain is aligned with monitoring changes in clinical status over time in people living with hereditary ataxia.
Rare disease therapeutics
The sponsor is involved in rare disease research with a therapeutic interest in conditions that have limited treatment options, particularly disorders affecting the nervous system and physical endurance.
- Orphan disease
- Inherited neurological disorder
- Clinical outcome measures
Its trial activity reflects a focus on therapeutic development for a genetically driven disease with substantial unmet medical need.
Exercise capacity and tolerability outcomes
Research interest also includes exercise capacity and treatment tolerability, using physical performance endpoints that capture stamina, workload, and patient response in a chronic neurological condition.
- Peak work capacity
- Exercise testing
- Safety and tolerability
This area connects functional assessment with the evaluation of therapeutic effects in Friedreich’s ataxia.
